573 results on '"Lloreta, Josep"'
Search Results
2. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights
3. Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis
4. Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities
5. Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer
6. FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression
7. The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer
8. Supplementary Tables 1-7 from The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors
9. Supplementary Figures 7 - 14, Tables 3 - 7 from Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma
10. Supplementary Material from Inflammatory-Related Genetic Variants in Non–Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment
11. Supplementary Figure Legends from Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma
12. Supplementary Figures 1 - 5, Tables 1 - 2 from Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma
13. Supplementary Figure 6 from Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma
14. Supplementary Figure S1 from Distinction between Asymptomatic Monoclonal B-cell Lymphocytosis with Cyclin D1 Overexpression and Mantle Cell Lymphoma: From Molecular Profiling to Flow Cytometry
15. Supplementary Figures 15 - 17, Table 8 from Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma
16. Supplementary Figure 3 from The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors
17. Supplementary Figure 1 from The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors
18. Supplementary Figure 2 from The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors
19. Supplementary Tables 1-6 from Distinction between Asymptomatic Monoclonal B-cell Lymphocytosis with Cyclin D1 Overexpression and Mantle Cell Lymphoma: From Molecular Profiling to Flow Cytometry
20. Supplementary Table 1 from PIK3CA Mutations Are an Early Genetic Alteration Associated with FGFR3 Mutations in Superficial Papillary Bladder Tumors
21. Data from The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease
22. Supplementary Table 2 from PIK3CA Mutations Are an Early Genetic Alteration Associated with FGFR3 Mutations in Superficial Papillary Bladder Tumors
23. Data from PIK3CA Mutations Are an Early Genetic Alteration Associated with FGFR3 Mutations in Superficial Papillary Bladder Tumors
24. Supplementary Materials, Figures 1 - 3, Tables 1 - 4, 6 - 8 from The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease
25. Supplementary Table 5 from The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease
26. The effect of smoking on prostate cancer survival : a cohort analysis in Barcelona
27. In vivo intratumoral Epstein–Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications
28. Multiple progressive annular telangiectasias: A clinicopathological variant of cutaneous collagenous vasculopathy?
29. Primary Ciliary Dyskinesia: Clinical Criteria Indicating Ultrastructural Studies
30. Discinesia ciliar primaria: criterios clínicos de indicación de estudio ultraestructural
31. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types
32. Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms
33. A 12-Gene Expression Signature Is Associated with Aggressive Histological in Prostate Cancer: SEC14L1 and TCEB1 Genes Are Potential Markers of Progression
34. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer
35. Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk
36. Epithelioid hemangioendothelioma of the cervical spine successfully treated with subtotal resection and radiotherapy
37. PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events
38. Concurrent TMPRSS2-ERG and SLC45A3-ERG Rearrangements Plus PTEN Loss Are Not Found in Low Grade Prostate Cancer and Define an Aggressive Tumor Subset
39. PROGNOSTIC VALUE OF DNA DAMAGE RESPONSE RELATED PROTEINS IN NON-MUSCLE INVASIVE BLADDER CANCER: MP45-12
40. Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas
41. Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels
42. Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer
43. FGFR3 mutations in prostate cancer: association with low-grade tumors
44. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
45. KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations
46. Activación de células satélite en el músculo intercostal de pacientes con EPOC
47. Activation of Satellite Cells in the Intercostal Muscles of Patients With Chronic Obstructive Pulmonary Disease
48. Lung Cancer OncoGuia
49. RISK OF BLADDER CANCER ASSOCIATED WITH FAMILY HISTORY OF CANCER: DO LOW-PENETRANCE POLYMORPHISMS ACCOUNT FOR THE INCREASE IN RISK?: MP22-02
50. Genome-wide association study identifies multiple loci associated with bladder cancer risk
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.